1,3-Dimethyl-2-(thiophen-2-yl)imidazolidine, 95.0%, 5g

2,3-Butadien-1-one, 1-(4-methoxyphenyl)-, 97%, 5g

2-(1-Chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol, 95.0%, 25g

(S)-3-(4-Fluorophenyl)morpholine hydrochloride, 97.0%, 1g

1-Methyl-4-(piperidin-4-yl)piperazine, 98.0%, 25g

4-Bromo-3-ethylaniline, 94.0%, 1g

HPLC Guard Columns (analytical) NUCLEODUR® C18 Gravity 1.8 µm, 3 Piece(s)

(S)-Diethyl 2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate 4-methylbenzenesulfonate, 97%, 10g

(1R,3S)-3-Aminocyclopentane-1-carboxylic acid hydrochloride, 97%, 5g

METHYL 4-BROMO-2-(TRIFLUOROMETHOXY)BENZOATE, 95.0%, 10g

2-methyl-4-(4-piperidinyl)pyrimidine dihydrochloride, 95.0%, 1g

5,6-Dichloro-3-iodo-1H-indazole, 97%, 100mg

6,7-DIFLUOROQUINAZOLIN-4(3H)-ONE, 95.0%, 250mg